Alpelisib Combo Does Not Extend PFS in High-Grade Serous Ovarian Cancer
Additional research on novel targeted therapies may be necessary to address the unmet needs in this high-grade serous ovarian cancer population.
Previous Post
Preparing for the AI-Driven Future of Neurology: Elisabeth Marsh, MD
Next Post
Stalking Associated With Higher Risk of CVD in Women
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago